Thrivent Financial For Lutherans Pulmonx Corp Transaction History

Thrivent Financial For Lutherans

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$21.13 - $35.65 $7.79 Million - $13.1 Million	-368,499 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$29.72 - $45.1 $83,988 - $127,452	2,826 Added 0.77%	368,499 $11.8 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $1.21 Million - $1.5 Million	33,644 Added 10.13%	365,673 $13.2 Million
Q2 2021 Aug 19, 2021	BUY	$37.61 - $48.0 $3.54 Million - $4.52 Million	94,113 Added 39.56%	332,029 $14.6 Million
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $3.07 Million - $4.71 Million	69,765 Added 41.49%	237,916 $10.9 Million

Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $6.61 Million - $11.6 Million	168,151 New	168,151 $11.6 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.